US FDA blocks drug imports from two Canadian Apotex facilities
This article was originally published in Scrip
Executive Summary
The US FDA has blocked entry into the country of drugs manufactured at two Apotex facilities in Ontario, Canada, owing to good manufacturing practice violations.